hematoxylin has been researched along with Brain Infarction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Croft, PR; Reichard, RR | 1 |
Christensen, T; Diemer, NH; Ensinger, HA; Wienrich, M | 1 |
Nakase, H; Okuno, S; Sakaki, T | 1 |
3 other study(ies) available for hematoxylin and Brain Infarction
Article | Year |
---|---|
Microscopic examination of grossly unremarkable pediatric dura mater.
Topics: Antigens, CD; Antigens, CD34; Antigens, Differentiation, Myelomonocytic; Brain Infarction; Coloring Agents; Dura Mater; Eosine Yellowish-(YS); Female; Forensic Pathology; Hematoma, Subdural; Hematoxylin; Humans; Infant; Infant, Newborn; Iron; Male; Microscopy; Staining and Labeling | 2009 |
The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study.
Topics: Acetamides; Animals; Astrocytes; Blood Pressure; Body Temperature; Brain Infarction; Disease Models, Animal; Hematoxylin; Immunohistochemistry; Infusions, Intravenous; Isoquinolines; Male; Neuroglia; Rats; Rats, Wistar; Survival | 2005 |
Comparative study of 2,3,5-triphenyltetrazolium chloride (TTC) and hematoxylin-eosin staining for quantification of early brain ischemic injury in cats.
Topics: Animals; Brain Infarction; Brain Ischemia; Cats; Coloring Agents; Eosine Yellowish-(YS); Female; Hematoxylin; Male; Neurons; Staining and Labeling; Telencephalon; Tetrazolium Salts | 2001 |